Table 5 Prevalence of amebiasis by age group of patients with IBD and the control group
From: Prevalence of amebiasis in inflammatory bowel disease in University Clinical Hospital Mostar
Age (years) | Broj (%) | ||||
|---|---|---|---|---|---|
Amebiasis | IBD | Control | x2 | p | |
≤37 | 9.676 | 0.002 | |||
Negative | 32 (74.4) | 40 (100.0) | |||
Positive | 11 (25.6) | 0 (0.0) | |||
Total | 43 (100) | 40 (100) | |||
38–52 | 4.492 | 0.049* | |||
Negative | 32 (84.2) | 41 (97.6) | |||
Positive | 6 (8.15) | 1 (2.4) | |||
Total | 38 (100) | 42 (100) | |||
≥53 | 0.320 | 1.000* | |||
Negative | 36 (94.75) | 36 (97.3) | |||
Positive | 2 (3.5) | 1 (2.7) | |||
Total | 38 (100) | 37 (100) | |||